Difference between revisions of "Part:BBa K3078005:Design"
(→References) |
(→References) |
||
Line 14: | Line 14: | ||
===References=== | ===References=== | ||
− | [1] | + | [1]Luo X L, Li J X, Huang H R, et al. LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation[J]. Front Immunol, 2019, 10: 283. |
+ | 5-14 | ||
− | [2] | + | [2]Den Hertog A L, Van Marle J, Van Veen H A, et al. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane[J]. Biochem J, 2005, 388(Pt 2): 689-95. |
Revision as of 00:04, 22 October 2019
LL-37
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Frame shift mutation should be avoided.
Source
This sequence was collected from the part BBa_K1162006.
References
[1]Luo X L, Li J X, Huang H R, et al. LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation[J]. Front Immunol, 2019, 10: 283. 5-14
[2]Den Hertog A L, Van Marle J, Van Veen H A, et al. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane[J]. Biochem J, 2005, 388(Pt 2): 689-95.